In one paragraphArticle in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
12 authors.
Jenny L CareyDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Miyuki HayashiDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0000-0001-8098-3024 Emily WelebobJefferson Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Department of Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0009-0003-6542-4736 Laura R GanserDepartment of Biophysics, Johns Hopkins University, Baltimore, MD 21218, USA.
Huan WangDepartment of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA.
Kerry BuckhaultsVickie and Jack Farber Institute for Neuroscience, Department of Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0000-0003-1427-1584 Jacquelyn A DePierroDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0009-0005-8454-8958 Zheng ShiDepartment of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA.ORCID 0000-0002-5214-1871 James ShorterDepartment of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0001-5269-8533 Aaron R HaeuslerJefferson Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Department of Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0000-0001-5566-3707 Lin GuoDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0000-0002-2589-9513 Funding
X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI Claudio Guillermo Giraudo · 1995 to 2026
$94.8MDefining the mechanistic basis of a prion disaggregaseR01GM099836 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI SHORTER, JAMES · 2013 to 2024
$3.9MElucidating the Mechanism in the Regulation of RNA-binding Protein Phase SeparationR35GM138109 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI Lin Guo · 2020 to 2026
$2.6MThe pathogenic relationship between neuronal activity and C9orf72-linked neurodegenerationRF1NS114128 · NINDS · THOMAS JEFFERSON UNIVERSITY · PI HAEUSLER, AARON RAYMOND · 2020 to 2021
$2.5MTraining Grant in Cellular, Biochemical and Molecular SciencesT32GM144302 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI DIANE E MERRY, PHILIP B WEDEGAERTNER · 2022 to 2026
$2.0MUnderstanding the viscoelasticity, surface tension, and membrane interactions of biomolecular condensates in live cellsR35GM147027 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI Zheng Shi · 2022 to 2026
$1.6MDeveloping RNA Oligonucleotides to Mitigate Abberant FUS Phase Transition in FTD/ALSR01NS121143 · NINDS · THOMAS JEFFERSON UNIVERSITY · PI GUO, LIN · 2024 to 2025
$741kThe pathogenic relationship between neuronal activity and C9orf72-linked neurodegenerationR01NS114128 · NINDS · THOMAS JEFFERSON UNIVERSITY · PI HAEUSLER, AARON RAYMOND · 2024 to 2024
$537kNCI NIH HHS P30 CA056036NIGMS NIH HHS R01 GM099836NIGMS NIH HHS R35 GM138109NIGMS NIH HHS R35 GM147027NIGMS NIH HHS T32 GM144302NINDS NIH HHS R01 NS114128NINDS NIH HHS R01 NS121143NINDS NIH HHS RF1 NS114128
6 · The paper itselfAbstract
FUS undergoes liquid-liquid phase separation (LLPS) to support essential cellular functions, but aberrant phase transitions promote toxic aggregation in neurodegenerative disease. Short RNA oligonucleotides can reverse this behavior, yet the structural determinants that govern RNA activity remain poorly defined. Here, we identify RNA G-quadruplexes (rG4s) as tunable structural motifs that potently modulate FUS LLPS. rG4 activity depends on its concentration and is modulated by rG4 length and stability: increasing repeat number switches rG4s from inhibitor to nucleator of FUS assembly, whereas chemical modifications that stabilize rG4 enhance inhibitory function and render these activities resilient to ionic perturbation. Although short rG4s interact with both soluble and condensed FUS, they preferentially engage the soluble pool, likely shifting the equilibrium toward dispersion. Leveraging these mechanistic insights, we developed a bioinformatic pipeline that uncovered more rG4 inhibitors that robustly reverse FUS LLPS and aggregation. Our findings establish rG4s as chemically programmable regulators of protein phase behavior and provide a blueprint for engineering RNA-based therapeutics that dissolve pathogenic FUS assemblies. More broadly, this work directly links RNA secondary structure to distinct functional outcomes in phase behavior, establishing a structure-function paradigm for RNA control of condensates, demonstrating implications in both fundamental biology and therapeutic development.
Identifiers
PMID41279901
PMCPMC12636609
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390